AarXiv13 Dec 2025

Multiscale Cross-Modal Mapping of Molecular, Pathologic, and Radiologic Phenotypes in Lipid-Deficient Clear Cell Renal CellCarcinoma

Ying Cui, Dongzhe Zheng, Ke Yu, Xiyin Zheng, Xiaorui Wang, Xinxiang Li, Yan Gu, Lin Fu, Xinyi Chen, Wenjie Mei, Xin-Gui Peng

Abstract

Corresponding Authors: Xin-Gui Peng, MD, PhD (Nurturing Center of Jiangsu Province for State Laboratory of AI Imaging & Interventional Radiology, Department of Radiology, Zhongda Hospital, School of Medicine, Southeast University, Nanjing, 210009, China. Email: [xinguipeng@seu.edu.cn)](mailto:xinguipeng@seu.edu.cn). Wenjie Mei, PhD (School of Robotics and Automation, Suzhou Campus, Nanjing University, 1520 Taihu Road, Suzhou, 215163, China. Email: [mei.wenjie@nju.edu.cn)](mailto:mei.wenjie@nju.edu.cn).

§ The Valyu brief

The paper, in five minutes

Read from the full text via Valyu Contents

A hierarchical cross‑scale AI framework predicts the aggressive lipid‑deficient clear cell renal carcinoma subtype preoperatively from pathology and CT, validated on 1,659 patients.

What’s new

i.Introduced a hierarchical cross‑scale framework for preoperative identification of DCCD‑ccRCC.
ii.Developed cross‑modal mapping that transfers molecular signatures to histology and CT phenotypes.
iii.Created PathoDCCD, a pathology model capturing multi‑scale microscopic features.
iv.Created RadioDCCD, a radiology model integrating whole‑tumor and habitat‑subregion radiomics with a heterogeneity metric.
v.Validated the framework across five cohorts totaling 1,659 patients, demonstrating reliable subtype prediction and risk stratification.

How they did it

The authors built a hierarchical framework that first maps molecular signatures onto pathology and radiology data, then trains modality‑specific models (PathoDCCD and RadioDCCD) that reflect tumor biology at different scales. These nested models were combined to predict the DCCD molecular subtype and assess clinical risk before surgery.

What they found

Validated on five independent cohorts comprising 1,659 patients.
PathoDCCD accurately recapitulated molecular subtypes across cohorts.
RadioDCCD provided reliable preoperative prediction of the DCCD subtype.
Patients identified by the models as high‑risk had the poorest clinical outcomes.

§ The Valyu brief

Reading the full paper and taking notes. This takes a few seconds…

§ Ask this paper

Ask a question about this paper

Valyu reads the full text and answers from what the paper actually says.

§ Related work in other archives

Multiscale Cross-Modal Mapping of Molecular, Pathologic, and Radiologic Phenotypes in Lipid-Deficient Clear Cell Renal CellCarcinoma

The paper, in five minutes

Ask a question about this paper

Similar papers in all four archives

The paper, in five minutes

Similar papers in all four archives